Jerry Gurwitz
Jerry Gurwitz
Unknown affiliation
Verified email at
Cited by
Cited by
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
Incidence and preventability of adverse drug events among older persons in the ambulatory setting
JH Gurwitz, TS Field, LR Harrold, J Rothschild, K Debellis, AC Seger, ...
Jama 289 (9), 1107-1116, 2003
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
DJ Graham, JA Staffa, D Shatin, SE Andrade, SD Schech, L La Grenade, ...
Jama 292 (21), 2585-2590, 2004
Reduction of bacteriuria and pyuria after ingestion of cranberry juice
J Avorn, M Monane, JH Gurwitz, RJ Glynn, I Choodnovskiy, LA Lipsitz
Jama 271 (10), 751-754, 1994
Incidence and preventability of adverse drug events in nursing homes
JH Gurwitz, TS Field, J Avorn, D McCormick, S Jain, M Eckler, M Benser, ...
The American journal of medicine 109 (2), 87-94, 2000
Optimising drug treatment for elderly people: the prescribing cascade
PA Rochon, JH Gurwitz
Bmj 315 (7115), 1096-1099, 1997
Temporal trends in cardiogenic shock complicating acute myocardial infarction
RJ Goldberg, NA Samad, J Yarzebski, J Gurwitz, C Bigelow, JM Gore
New England Journal of Medicine 340 (15), 1162-1168, 1999
Antipsychotic drug use and mortality in older adults with dementia
SS Gill, SE Bronskill, SLT Normand, GM Anderson, K Sykora, K Lam, ...
Annals of internal medicine 146 (11), 775-786, 2007
Prescription drug use in pregnancy
SE Andrade, JH Gurwitz, RL Davis, KA Chan, JA Finkelstein, K Fortman, ...
American journal of obstetrics and gynecology 191 (2), 398-407, 2004
The exclusion of the elderly and women from clinical trials in acute myocardial infarction
JH Gurwitz, NF Col, J Avorn
Jama 268 (11), 1417-1422, 1992
Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women
KA Chan, SE Andrade, M Boles, DSM Buist, GA Chase, JG Donahue, ...
The Lancet 355 (9222), 2185-2188, 2000
Risk factors for adverse drug events among nursing home residents
TS Field, JH Gurwitz, J Avorn, D McCormick, S Jain, M Eckler, M Benser, ...
Archives of internal medicine 161 (13), 1629-1634, 2001
The incidence of adverse drug events in two large academic long-term care facilities
JH Gurwitz, TS Field, J Judge, P Rochon, LR Harrold, C Cadoret, M Lee, ...
The American journal of medicine 118 (3), 251-258, 2005
Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial
SB Soumerai, TJ McLaughlin, JH Gurwitz, E Guadagnoli, PJ Hauptman, ...
Jama 279 (17), 1358-1363, 1998
Patients at-risk for cost-related medication nonadherence: a review of the literature
BA Briesacher, JH Gurwitz, SB Soumerai
Journal of general internal medicine 22, 864-871, 2007
The ambiguous relation between aging and adverse drug reactions
JH Gurwitz, J Avorn
Annals of Internal Medicine 114 (11), 956-966, 1991
A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis
PA Rochon, JH Gurwitz, RW Simms, PR Fortin, DT Felson, KL Minaker, ...
Archives of Internal Medicine 154 (2), 157-163, 1994
The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review
JI Wolfstadt, JH Gurwitz, TS Field, M Lee, S Kalkar, W Wu, PA Rochon
Journal of general internal medicine 23, 451-458, 2008
Risk factors for adverse drug events among older adults in the ambulatory setting
TS Field, JH Gurwitz, LR Harrold, J Rothschild, KR DeBellis, AC Seger, ...
Journal of the American Geriatrics Society 52 (8), 1349-1354, 2004
The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly
M Monane, RL Bohn, JH Gurwitz, RJ Glynn, R Levin, J Avorn
American Journal of Hypertension 10 (7), 697-704, 1997
The system can't perform the operation now. Try again later.
Articles 1–20